JCR Pharmaceuticals Presents Investigational Lysosomal Disorder Data at 2026 MPS Symposium

JCR Pharmaceuticals presented its latest research at a major scientific meeting. The event was the 18th International Symposium on MPS and Related Lysosomal Diseases. The symposium took place in 2026 and focuses on mucopolysaccharidosis and lysosomal disorders. JCR showcased data from its investigational treatments targeting lysosomal storage disorders. The presented data highlighted progress in therapeutic development for these rare diseases. Attendees included researchers, clinicians, and industry representatives. The company aims to advance its pipeline toward clinical trials. The presentation underscores ongoing efforts to address unmet medical needs.